← Eichor
Study identifier: NCT06856447 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

Condition: Colorectal Cancer  ·  Sponsor: toqa saad mohammed mohammed

PhasePhase 1
Planned participants22
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This study aims to evaluate the possible beneficial role of coenzyme Q10 against oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer.

This description comes directly from the study's public registry record.

Talk to the study team

toqa saad mohammed mohammed, master  ·  01096266316  ·  toqasaad45@gmail.com

Tarek pro Mostafa mohamed, pro  ·  01154594035  ·  Tarek77@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ain-Shams University HospitalCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06856447